Teleflex Secures FDA Breakthrough Status for Heart Device
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has received U.S. Food and Drug Administration Breakthrough Device Designation for its Freesolve Resorbable Magnesium Scaffold in coronary artery procedures, potentially accelerating the …
Teleflex Secures FDA Breakthrough Status for Heart Device Read More